| 000 | 01226cam a2200373 a 4500 | ||
|---|---|---|---|
| 999 |
_c19148 _d19148 |
||
| 003 | BD-ChIIU | ||
| 005 | 20230205020003.0 | ||
| 008 | 2020 s2013 ch b 001 0 eng | ||
| 010 | _a 2012047645 | ||
| 020 | _a9780702042911 | ||
| 020 | _a9780702042911 (International) | ||
| 035 | _a(DNLM)101596715 | ||
| 040 |
_aDNLM/DLC _cBD-ChIIU _dBD-ChIIU |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aRS200 _b.A95 2007 |
| 060 | 1 | 0 | _aQV 786 |
| 082 | 0 | 0 |
_a615.19 _224 _bA926 2013 |
| 245 | 0 | 0 |
_aAulton's pharmaceutics : _bthe design and manufacture of medicines / _cedited by Michael E. Aulton and Kevin M.G. Taylor. |
| 246 | 1 | _aPharmaceutics | |
| 250 | _a4th ed. | ||
| 260 |
_aChina : _bChurchill Livingstone/Elsevier, _c2013. |
||
| 300 |
_axiii, 894 p. ; _c25 cm. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 590 | _aMd. Nurul Islam | ||
| 650 | 1 | 2 | _aDosage Forms. |
| 650 | 2 | 2 |
_aBiopharmaceutics _xmethods. |
| 650 | 2 | 2 |
_aDrug Compounding _xmethods. |
| 650 | 2 | 2 | _aDrug Design. |
| 700 | 1 | _aAulton, Michael E. | |
| 700 | 1 |
_aTaylor, Kevin, _d1961- |
|
| 906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
| 942 |
_2ddc _cBK _03 |
||